(Q42813063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Glucan particles for selective delivery of siRNA to phagocytic cells in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Gregory J Tesz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Myriam Aouadi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Matthieu Prot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sarah M Nicoloro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Emilie Boutet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Shinya U Amano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Anca Goller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mengxi Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Chang-An Guo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

William E Salomon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Rebecca A Baum

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mark J O'Connor

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ernesto Soto

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gary R Ostroff

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Michael P Czech

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

351-362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

RNAi therapeutics: a potential new class of pharmaceutical drugs

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Small silencing RNAs: an expanding universe

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

RNAi-based therapeutics-current status, challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Novel RNA-based strategies for therapeutic gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

A status report on RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

The inflammatory macrophage: a story of Jekyll and Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Dectin-1 and its role in the recognition of beta-glucans by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Endo-Porter: a novel reagent for safe, effective delivery of substances into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Cell-penetrating peptides: tools for intracellular delivery of therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

High efficiency lipid-based siRNA transfection of adipocytes in suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

The immune response in atherosclerosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Macrophages, inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

A comprehensive review of interventions in the NOD mouse and implications for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

Macrophages and tissue injury: agents of defense or destruction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110352

21 January 2018

Identifiers

DOI

10.1042/BJ20110352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418037%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference